Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

28
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
28
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

25
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
25
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

15
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
15
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

21
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
21
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

21
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
21
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

23
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
23

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Cardiac magnetic resonance imaging in patients referred for premature ventricular contractions: identifying patients most likely to benefit.

Frontiers in cardiovascular medicine·2026
Same author

Concomitant Hypertension in Hypertrophic Cardiomyopathy: Clinical Phenotype and Prognostic Associations of Cardiovascular Magnetic Resonance Biomarkers.

European journal of preventive cardiology·2026
Same author

Prognostic Impact of LGE Granularity Using CMR in End‑Stage Hypertrophic Cardiomyopathy.

Circulation. Cardiovascular imaging·2026
Same author

Drug Adherence After Hospitalisation for Heart Failure: What Have We Learned from a French Survey?

Journal of clinical medicine·2026
Same author

Cost-effectiveness of TTVR with EVOQUE system in patients with Severe Tricuspid Regurgitation based on TRISCEND II trial.

ESC heart failure·2026
Same author

The Spectrum of Iatrogenic Valvular Heart Disease.

JACC. Case reports·2026

Related Experiment Video

Updated: Jul 31, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

3.9K

Arrhythmic mitral valve prolapse in 2023: Evidence-based update.

Maciej Kubala1,2, Benjamin Essayagh3,4, Hector I Michelena3

  • 1Department of Cardiology, Amiens University Hospital, Amiens, France.

Frontiers in Cardiovascular Medicine
|May 5, 2023
PubMed
Summary

Mitral valve prolapse (MVP) can cause dangerous ventricular arrhythmias, even sudden cardiac death. Research is needed to better predict risk and manage these "arrhythmic MVP" cases.

Keywords:
mitral valve prolapse (MPV)premature ventricular contractionsrisk stratificationsudden cardiac death (SCD)ventricular tachycardia (VT)

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.7K
An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
07:42

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat

Published on: May 19, 2020

7.1K

Related Experiment Videos

Last Updated: Jul 31, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

3.9K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.7K
An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
07:42

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat

Published on: May 19, 2020

7.1K

Area of Science:

  • Cardiology
  • Electrophysiology
  • Sudden Cardiac Death Research

Background:

  • Mitral valve prolapse (MVP) is associated with ventricular arrhythmias, posing a risk for sudden cardiac death.
  • A subset of patients, termed "arrhythmic MVP," experience frequent or complex ventricular arrhythmias without other identifiable causes.
  • The link between MVP, arrhythmias, and sudden cardiac death is underappreciated and requires further investigation.

Purpose of the Study:

  • To review current evidence on the diagnosis, prognosis, and management of ventricular arrhythmias in patients with MVP.
  • To identify potential risk factors for sudden cardiac death in arrhythmic MVP.
  • To highlight knowledge gaps and propose a research agenda for arrhythmic MVP.

Main Methods:

  • Comprehensive literature review of diagnostic approaches, prognostic implications, and therapeutic strategies for MVP-related ventricular arrhythmias.
  • Analysis of existing data on risk factors and sudden cardiac death in arrhythmic MVP.
  • Summary of current guidelines for managing ventricular arrhythmias in MVP patients.

Main Results:

  • Arrhythmic MVP is an underrecognized cause of sudden cardiac death, particularly in younger individuals.
  • Left ventricular remodeling may complicate the coexistence of MVP and ventricular arrhythmias.
  • Evidence linking MVP-associated arrhythmias to sudden cardiac death is limited, and risk prediction remains challenging.

Conclusions:

  • Current understanding of arrhythmic MVP's pathophysiology, prognosis, and optimal management is incomplete.
  • Further prospective research is essential for developing reliable risk prediction models.
  • Targeted therapies, including ICDs and catheter ablation, are important management options.